RNAi技術の市場規模、シェア、動向分析レポート：製品・サービス別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

RNAi技術市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のRNAi技術市場規模は2030年までに66億5,000万米ドルに達すると予測され、2024年から2030年までのCAGRは14.6%で成長しています。

技術の進歩と創薬・薬剤開発への応用の増加は、予測期間中にRNAi技術の需要を増加させると予測されています。

COVID-19パンデミックは市場に好影響を与えています。COVID-19に対する効果的な治療法やワクチンの開発が急務となり、RNAiを含むRNAベースの技術への資金提供や投資が急増しました。政府、製薬会社、バイオテクノロジー企業はRNA研究に多額の投資を行い、RNAi療法の開発と商業化を加速させました。このため、予測期間中、RNAi技術の需要が増加しています。

さらに、ヘルスケアへの政府投資の拡大は、予測期間中の市場成長を促進すると予測されています。政府や関連機関は、バイオ医薬品による治療を推進することで、感染症に対するヘルスケア支出を最小限に抑える努力をしています。国際的なヘルスケア機関は、様々な疾患に対する認知度の向上と新たな治療法の発見に貢献しています。新薬治療を導入するための臨床研究に対する外部からの資金援助の増加は、製品開発にとって極めて重要です。疾病負担を軽減するドラッグデリバリープラットフォームの開発を促進する政府主導の取り組みが、市場拡大の原動力となっています。

しかし、未開発国では熟練した専門家や研究支援が大幅に不足しており、ダイナミックな市場への参入に大きな影響を与えています。十分な訓練を受けた労働力の不足は、教育格差や継続的なトレーニング機会の不足によって悪化しています。同時に、限られた研究資金、インフラの不備、規制の複雑さが、これらの地域における科学の進歩を妨げています。このことが、予測期間中の市場成長の妨げになると予想されます。

RNAi技術市場レポートハイライト

• 2023年の製品・サービス市場は、製品分野が最も高い収益シェアを占めました。製品セグメントはさらにmiRNA、siRNA、その他に区分されます。これは、製品の普及率が高く、キット&試薬の使用率が高いことに起因しています。一方、サービスは予測期間中に最も速い速度で成長すると予想されています。
• 用途別では、創薬・医薬品開発分野が2023年に68.87%の最大市場シェアを占め、予測期間中に最も速い速度で成長すると予測されています。これは、新薬に対する需要の増加と技術進歩の拡大に起因しています。
• 最終用途に基づくと、製薬＆バイオテクノロジー企業が2023年に56.54％の最大収益シェアでセグメントを支配しました。一方、CRO&CMOは予測期間中に最も速いCAGRで成長すると予測されています。
• 北米地域は、強固なヘルスケアインフラ、先進医療技術の高い導入率、バイオ医薬品研究開発への多額の投資により、2023年に38.54%の市場シェアを占めました。一方、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場見通し
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 RNAi技術市場：製品およびサービスのビジネス分析

• 製品およびサービスのセグメントダッシュボード
• 世界のRNAi技術市場の製品とサービスの変動分析
• 世界のRNAi技術市場規模と動向分析、製品とサービス別、2018年から2030年
• 製品
• サービス

第5章 RNAi技術市場：用途のビジネス分析

• 用途のセグメントダッシュボード
• 世界のRNAi技術市場の用途、変動分析
• 世界のRNAi技術市場規模と動向分析、用途別、2018～2030年
• 医薬品の発見と開発
• 機能ゲノミクス
• その他

第6章 RNAi技術市場：最終用途のビジネス分析

• 最終用途のセグメントダッシュボード
• 世界のRNAi技術市場の最終用途変動分析
• 世界のRNAi技術市場規模と動向分析、最終用途別、2018～2030年
• 製薬・バイオテクノロジー企業
• 学術研究機関
• CROとCMO

第7章 RNAi技術市場：製品・サービス、用途、最終用途別の地域推定・動向分析

• 地域ダッシュボード
• 市場規模と予測および動向分析、2018年から2030年
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 参入企業
• 戦略マッピング
• 企業市況分析、2023年
• 参入企業の概要
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Creative Biolabs
  • GenScript
  • Revvity
  • Promega Corporation
  • OriGene Technologies, Inc.
  • Altogen Biosystems
  • Danaher
  • Bioneer Corporation

第9章 アナリストの見解

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 4 Global RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 5 Global RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 6 Global RNAi technology market, by region, 2018 - 2030 (USD Million)
• Table 7 North America RNAi technology market, by country, 2018 - 2030 (USD Million)
• Table 8 North America RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 9 North America RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 10 North America RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 11 U.S. RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 12 U.S. RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 13 U.S. RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 14 Canada RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 15 Canada RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 16 Canada RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 17 Mexico RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 18 Mexico RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 19 Mexico RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Europe RNAi technology market, by country, 2018 - 2030 (USD Million)
• Table 21 Europe RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 22 Europe RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 23 Europe RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 24 UK RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 25 UK RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 26 UK RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 27 Germany RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 28 Germany RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 29 Germany RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 30 France RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 31 France RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 32 France RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 33 Italy RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 34 Italy RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 35 Italy RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 36 Spain RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 37 Spain RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 38 Spain RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 39 Denmark RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 40 Denmark RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 41 Denmark RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 42 Sweden RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 43 Sweden RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 44 Sweden RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 45 Norway RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 46 Norway RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 47 Norway RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific RNAi technology market, by country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 52 Japan RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 53 Japan RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 54 Japan RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 55 China RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 56 China RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 57 China RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 58 India RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 59 India RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 60 India RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Australia RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 62 Australia RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 63 Australia RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 64 Thailand RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 65 Thailand RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 66 Thailand RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 67 South Korea RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 68 South Korea RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 69 South Korea RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 70 Latin America RNAi technology market, by country, 2018 - 2030 (USD Million)
• Table 71 Latin America RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 72 Latin America RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 73 Latin America RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 74 Brazil RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 75 Brazil RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 76 Brazil RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 77 Argentina RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 78 Argentina RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 79 Argentina RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa RNAi technology market, by country, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 84 South Africa RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 85 South Africa RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 86 South Africa RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 90 UAE RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 91 UAE RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 92 UAE RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 93 Kuwait RNAi technology market, by product & service, 2018 - 2030 (USD Million)
• Table 94 Kuwait RNAi technology market, by application, 2018 - 2030 (USD Million)
• Table 95 Kuwait RNAi technology market, by end-use, 2018 - 2030 (USD Million)
• Table 96 Participant's overview
• Table 97 Financial performance
• Table 98 Key companies undergoing expansions
• Table 99 Key companies undergoing acquisitions
• Table 100 Key companies undergoing collaborations
• Table 101 Key companies launching new products
• Table 102 Key companies undertaking other strategies

List of Figures

• Fig. 1 RNAi technology market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market formulation & validation
• Fig. 7 Market outlook
• Fig. 8 Segment snapshot
• Fig. 9 Competitive landscape snapshot
• Fig. 10 Parent market outlook
• Fig. 11 RNAi technology market driver analysis
• Fig. 12 RNAi technology market restraint analysis
• Fig. 13 RNAi technology market: Porter's analysis
• Fig. 14 RNAi technology market: PESTEL analysis
• Fig. 15 RNAi technology market: Product & service outlook and key takeaways
• Fig. 16 RNAi technology market: Product & service market share analysis, 2023 - 2030
• Fig. 17 Global RNAi technology by products market, 2018 - 2030 (USD Million)
• Fig. 18 Global RNAi technology by miRNA market, 2018 - 2030 (USD Million)
• Fig. 19 Global RNAi technology by siRNA market, 2018 - 2030 (USD Million)
• Fig. 20 Global RNAi technology by others market, 2018 - 2030 (USD Million)
• Fig. 21 Global RNAi technology by service market, 2018 - 2030 (USD Million)
• Fig. 22 RNAi technology market: Application outlook and key takeaways
• Fig. 23 RNAi technology market: Application market share analysis, 2023 - 2030
• Fig. 24 Global RNAi technology by drug discovery & dvelopment market, 2018 - 2030 (USD Million)
• Fig. 25 Global RNAi technology by neurology market, 2018 - 2030 (USD Million)
• Fig. 26 Global RNAi technology by oncology market, 2018 - 2030 (USD Million)
• Fig. 27 Global RNAi technology by infectious diseases market, 2018 - 2030 (USD Million)
• Fig. 28 Global RNAi technology by metabolic diseases market, 2018 - 2030 (USD Million)
• Fig. 29 Global RNAi technology by others market, 2018 - 2030 (USD Million)
• Fig. 30 Global RNAi technology by functional genomics market, 2018 - 2030 (USD Million)
• Fig. 31 Global RNAi technology others market, 2018 - 2030 (USD Million)
• Fig. 32 RNAi technology market: End-use outlook and key takeaways
• Fig. 33 RNAi technology market: End-use market share analysis, 2023 - 2030
• Fig. 34 Global RNAi technology by pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
• Fig. 35 Global RNAi technology by academic & research institutes market, 2018 - 2030 (USD Million)
• Fig. 36 Global RNAi technology by CROs & CMOs market, 2018 - 2030 (USD Million)
• Fig. 37 Regional marketplace: Key takeaways
• Fig. 38 North America RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 U.S. RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Canada RNAi technology market, 2018 - 2030 (USD Million)
• Fig. 41 Mexico RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Europe RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 UK RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Germany RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 France RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Italy RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Spain RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Denmark RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 49 Sweden RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 Norway RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Asia Pacific RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 Japan RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 China RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 India RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Australia RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Thailand RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 South Korea RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Latin America RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 Brazil RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Argentina RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 MEA RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 South Africa RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Saudi Arabia RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 UAE RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Kuwait RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 Key company categorization
• Fig. 67 Company market positioning
• Fig. 68 Market participant categorization
• Fig. 69 Strategy framework

RNAi Technology Market Growth & Trends:

The global RNAi technology market size is anticipated to reach USD 6.65 billion by 2030 and is growing at a CAGR of 14.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing technological advancements and increasing applications in drug discovery and development are anticipated to increase the demand for RNAi technology over the forecast period.

The COVID-19 pandemic has had a positive impact on the market. The urgency to develop effective treatments and vaccines for COVID-19 led to a surge in funding and investments in RNA-based technologies, including RNAi. Governments, pharmaceutical companies, and biotech firms invested heavily in RNA research, accelerating the development and commercialization of RNAi therapies. This has increased the demand for RNAi technologies during the forecast period.

Moreover, growing government investments in healthcare are anticipated to fuel market growth over the forecast period. The government and relevant bodies are taking efforts to minimize healthcare expenditure on infectious diseases by promoting biopharmaceutical treatments. International healthcare institutions contribute to raising awareness and the discovery of new therapies for various disorders. Increasing external funding for clinical studies to introduce new drug treatments is pivotal for product development. Government-led initiatives to expedite the development of drug delivery platforms for reducing disease burden are driving market expansion.

However, undeveloped countries have a substantial shortage of skilled professionals and research support, profoundly impacting their participation in the dynamic market. The scarcity of a well-trained workforce is exacerbated by educational disparities and a lack of continuous training opportunities. Simultaneously, limited research funding, infrastructure shortcomings, and regulatory complexities impede scientific progress in these regions. This is anticipated to hamper the market's growth over the forecast period.

RNAi Technology Market Report Highlights:

• The products segment dominated the product & services market with the highest revenue share in 2023. The product segment is further segmented into miRNA, siRNA, and others. This is attributed to the high product penetration and high usage of kits & reagents. On the other hand, services are expected to grow at the fastest rate over the forecast period
• The drug discovery & development segment held the largest market share of 68.87% in 2023 for the application segment and is anticipated to grow at the fastest rate over the forecast period. This is attributed to the increasing demand for new drugs and growing technological advancements
• Based on end-use, pharmaceutical & biotechnology companies dominated the segment with the largest revenue share of 56.54% in 2023. On the other hand, CROs & CMOs are anticipated to grow at the fastest CAGR over the forecast period
• The North American region dominated the market share of 38.54% in 2023 due to its robust healthcare infrastructure, high adoption rates of advanced medical technologies, and significant investments in biopharmaceutical research and development. On the other hand, Asia Pacific anticipated growing at the highest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Region
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing applications of RNAi technology in research and medicine
    • 3.2.1.2. Growing interest in personalized medicine
    • 3.2.1.3. Technological advancements in RNAi techniques
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of skilled professionals and research support in developing countries
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. RNAi Technology Market: Product & Service Business Analysis

• 4.1. Product & Service Segment Dashboard
• 4.2. Global RNAi Technology Market Product & Service Movement Analysis
• 4.3. Global RNAi Technology Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
• 4.4. Products
  • 4.4.1. Global Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. miRNA
    • 4.4.2.1. Global miRNA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. siRNA
    • 4.4.3.1. Global siRNA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Global Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. RNAi Technology Market: Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global RNAi Technology Market Application, Movement Analysis
• 5.3. Global RNAi Technology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Drug Discovery & Development
  • 5.4.1. Global Drug Discovery & Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Neurology
    • 5.4.2.1. Global Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Oncology
    • 5.4.3.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. Infectious Diseases
    • 5.4.4.1. Global Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.5. Metabolic Diseases
    • 5.4.5.1. Global Metabolic Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.6. Others
    • 5.4.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Functional Genomics
  • 5.5.1. Global Functional Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. RNAi Technology Market: End-use Business Analysis

• 6.1. End-use Segment Dashboard
• 6.2. Global RNAi Technology Market End-use Movement Analysis
• 6.3. Global RNAi Technology Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceutical & Biotechnology Companies
  • 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Academic & Research Institutes
  • 6.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. CROs & CMOs
  • 6.6.1. Global CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. RNAi Technology Market: Regional Estimates & Trend Analysis by Product & Services, Application, End-use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. North America RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Mexico RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. UK RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Germany RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. France RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Italy RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Spain RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Denmark RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Sweden RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Framework
    • 7.4.9.4. Norway RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Japan RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. China RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. India RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Australia RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Thailand RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. South Korea
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. South Korea RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Brazil RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Argentina RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Saudi Arabia RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. UAE RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Kuwait RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2023
• 8.4. Participant's Overview
  • 8.4.1. Thermo Fisher Scientific, Inc.
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Merck KGaA
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Creative Biolabs
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. GenScript
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Revvity
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Promega Corporation
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. OriGene Technologies, Inc.
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Altogen Biosystems
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Danaher
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Bioneer Corporation
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives

Chapter 9. Analyst View